Back to top
more

Merck & Co. (MRK)

(Delayed Data from NYSE)

$109.77 USD

109.77
9,704,771

-0.41 (-0.37%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $109.53 -0.24 (-0.22%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 19% (47 out of 252)

Industry: Large Cap Pharmaceuticals

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for MRK

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Merck & Co, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 7,093 13,192 8,096 8,062 10,450
Receivables 10,349 9,450 9,230 7,851 6,778
Notes Receivable 0 0 0 0 0
Inventories 6,358 5,911 5,953 6,310 5,978
Other Current Assets 8,368 7,169 6,987 5,541 4,277
Total Current Assets 32,168 35,722 30,266 27,764 27,483
Net Property & Equipment 23,051 21,422 19,279 17,986 15,053
Investments & Advances 252 1,015 370 785 1,469
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 39,208 41,473 44,197 34,842 33,621
Deposits & Other Assets 11,996 9,528 11,582 10,211 6,771
Total Assets 106,675 109,160 105,694 91,588 84,397
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 1,372 1,946 2,412 6,431 3,610
Accounts Payable 3,922 4,264 4,609 4,594 3,738
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 15,766 14,159 13,859 13,053 12,549
Income Taxes Payable 2,649 1,986 1,224 1,575 736
Other Current Liabilities 1,985 1,884 1,768 1,674 1,587
Total Current Liabilities 25,694 24,239 23,872 27,327 22,220
Mortgages 0 0 0 0 0
Deferred Taxes/Income 871 1,795 3,441 1,015 1,470
Convertible Debt 0 0 0 0 0
Long-Term Debt 33,683 28,745 30,690 25,360 22,736
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 8,792 8,323 9,434 12,482 11,970
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 69,040 63,102 67,437 66,184 58,396
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1,788 1,788 1,788 1,788 1,788
Capital Surplus 44,509 44,379 44,238 39,588 39,660
Retained Earnings 53,895 61,081 53,696 47,362 46,602
Other Equity -5,107 -4,701 -4,356 -6,547 -6,099
Treasury Stock 57,450 56,489 57,109 56,787 55,950
Total Shareholder's Equity 37,635 46,058 38,257 25,404 26,001
Total Liabilities & Shareholder's Equity 106,675 109,160 105,694 91,588 84,397
Total Common Equity 37,635 46,058 38,257 25,404 26,001
Shares Outstanding 2,534.00 2,535.40 2,527.60 2,530.00 2,545.90
Book Value Per Share 14.85 18.17 15.14 10.04 10.21

Fiscal Year End for Merck & Co, Inc falls in the month of December.

All items in Millions except Per Share data.

9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023
Assets          
Cash & Equivalents 11,354 5,619 7,093 8,773 6,378
Receivables 11,642 11,366 10,349 10,394 11,030
Notes Receivable 0 0 0 0 0
Inventories 6,469 6,510 6,358 6,131 5,930
Other Current Assets 8,740 7,950 8,368 6,656 6,639
Total Current Assets 38,205 31,445 32,168 31,954 29,977
Net Property & Equipment 23,221 23,045 23,051 22,526 22,231
Investments & Advances 357 280 252 1,306 1,214
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 38,145 38,753 39,208 40,382 40,860
Deposits & Other Assets 12,702 12,326 11,996 10,559 10,187
Total Assets 112,630 105,849 106,675 106,727 104,469
Liabilities & Shareholders Equity 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023
Notes Payable 3,071 3,077 1,372 887 2,839
Accounts Payable 3,519 3,514 3,922 3,509 3,442
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 14,712 14,102 15,766 14,840 13,747
Income Taxes Payable 2,777 2,398 2,649 1,981 1,489
Other Current Liabilities 1,981 2,008 1,985 1,877 1,877
Total Current Liabilities 26,060 25,099 25,694 23,094 23,394
Mortgages 0 0 0 0 0
Deferred Taxes/Income 876 922 871 1,018 996
Convertible Debt 0 0 0 0 0
Long-Term Debt 34,717 31,142 33,683 33,972 34,072
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 7,329 8,792 7,343 7,265
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 68,982 65,425 69,040 65,427 65,727
Shareholders Equity 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1,788 1,788 1,788 1,788 1,788
Capital Surplus 44,362 44,598 44,509 44,358 44,219
Retained Earnings 60,187 56,697 53,895 57,082 54,198
Other Equity -5,295 -5,214 -5,107 -4,862 -4,851
Treasury Stock 57,394 57,445 57,450 57,066 56,612
Total Shareholder's Equity 43,648 40,424 37,635 41,300 38,742
Total Liabilities & Shareholder's Equity 112,630 105,849 106,675 106,727 104,469
Total Common Equity 43,648 40,424 37,635 41,300 38,742
Shares Outstanding 2,532.80 2,533.00 2,534.00 2,537.50 2,537.40
Book Value Per Share 17.23 15.96 14.85 16.28 15.27